Laurus Labs has successfully completed the US Food and Drug Administration (USFDA) inspection of its unit-6 API intermediate facility with one observation, which is related to a procedure, on November 02, 2018.
The manufacturing facility unit-6 is located at Atchutapuram in Visakhapatnam, Andhra Pradesh and has 42 reactors with 253 kilo-liters capacity.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
